In the current study, the effects of resveratrol on the levels of inflammatory cytokines were explored and the potential mechanism of TLR4/HIF‐1α signalling pathway was studied, which offers a new spectrum of clinical treatment in DM. This evidence concerns the gene HIF1A and diabetes mellitus.